BIOMARIN PHARMACEUTICAL INC (BMRN) Net Cash Provided by (Used in) Financing Activities USD 2010 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Biomarin Pharmaceutical Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$42.8 M, a 5.03% decline year-over-year.
  • Biomarin Pharmaceutical Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$18.7 M, a 0.41% decline from 2022.
  • Biomarin Pharmaceutical Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$18.7 M, a 38754% decline from 2021.
  • Biomarin Pharmaceutical Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$48 K, a 100% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$18.7 M -$77 K -0.41% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 -$18.7 M -$18.6 M -38754% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 -$48 K* -$181 M -100% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $181 M +$256 M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$74.7 M +$313 M +80.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 -$388 M -$895 M -177% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $507 M -$220 M -30.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $727 M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2013 $747 M +$434 M +139% Jan 1, 2013 Dec 31, 2013 10-K 2014-02-26
2012 $312 M +$283 M +964% Jan 1, 2012 Dec 31, 2012 10-K 2014-02-26
2011 $29.3 M +$25.8 M +737% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-26
2010 $3.5 M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.